{"SPADE_UN_15840": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15840", "Peptide Name": 17, "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GLLALLGELAEHLGSKI", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (EC50>100 Î¼M)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C79H136N20O23", "Mass": 1734.05, "PI": 5.4, "Net Charge": 0, "Hydrophobicity": 0.87, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "De novo design of anticancer peptides by ensemble artificial neural networks", "Pubmed ID": "30953170", "Reference": "J Mol Model. 2019 Apr 5;25(5)112.", "Author": "Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30953170"}], "Frequent Amino Acids": "LGA", "Absent Amino Acids": "CDFMNOPQRTUVWY", "Basic Residues": 2, "Acidic Residues": 2, "Hydrophobic Residues": 9, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_09732", "Similarity": 0.8333333333333334, "Sequence": "RRKKAAVALLPAVLLALL"}, {"SPADE_ID": "SPADE_UN_10984", "Similarity": 0.8333333333333334, "Sequence": "MQHRGFLLLTLLALL"}, {"SPADE_ID": "SPADE_UN_21348", "Similarity": 0.8, "Sequence": "KKKKKKKKKGGGLLALLALLA"}]}}}